Commentary on “Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects”
oleh: Yuning Wang, Guo Zhao, Shujun Xing, Shuhang Wang, Ning Li
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-08-01 |
Deskripsi
Subjek
CAR-T cell therapy; Mesothelin; Tumor antigen epitope; IL-12; Combination treatment